Table of Contents
ISRN Nephrology
Volume 2013, Article ID 351364, 6 pages
http://dx.doi.org/10.5402/2013/351364
Clinical Study

Usefulness of Change in Estimated Glomerular Filtration Rate as a Predicting Factor of Progression of Chronic Kidney Disease

1Division of Nephrology, Department of Internal Medicine, Juntendo University Nerima Hospital, 3-1-10 Takanodai, Nerima-ku, Tokyo 177-8521, Japan
2Division of Nephrology, Department of Internal Medicine, Juntendo University School of Medicine, 2-1-1 Hongo, Bunkyo-ku, Tokyo 113-8421, Japan

Received 23 July 2012; Accepted 13 August 2012

Academic Editors: C. Escobar, A. Sikole, and A. Tzamaloukas

Copyright © 2013 Kunimi Maeda et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. S. Nakai, K. Suzuki, I. Masakane et al., “Overview of regular dialysis treatment in Japan (as of 31 December 2008),” Therapeutic Apheresis and Dialysis, vol. 14, no. 6, pp. 505–540, 2010. View at Publisher · View at Google Scholar · View at Scopus
  2. Clinical Practice Guidebook for Diagnosis and Treatment of Chronic Kidney Disease, Japanese Society of Nephrology, 2009.
  3. S. Matsuo, E. Imai, M. Horio et al., “Collaborators developing the Japanese equation for estimated GFR: revised equations for estimated GFR from serum creatinine in Japan,” American Journal of Kidney Diseases, vol. 53, no. 6, pp. 982–992, 2009. View at Publisher · View at Google Scholar · View at Scopus
  4. M. Evans, J. P. Fryzek, C. G. Elinder et al., “The natural history of chronic renal failure: Results from an unselected, population-based, inception cohort in Sweden,” American Journal of Kidney Diseases, vol. 46, no. 5, pp. 863–870, 2005. View at Publisher · View at Google Scholar · View at Scopus
  5. A. Serrano, J. Huang, C. Ghossein et al., “Stabilization of glomerular filtration rate in advanced chronic kidney disease: a two-year follow-up of a cohort of chronic kidney disease patients stages 4 and 5,” Advances in Chronic Kidney Disease, vol. 14, no. 1, pp. 105–112, 2007. View at Publisher · View at Google Scholar · View at Scopus
  6. K. Iseki, Y. Ikemiya, C. Iseki, and S. Takishita, “Proteinuria and the risk of developing end-stage renal disease,” Kidney International, vol. 63, no. 4, pp. 1468–1474, 2003. View at Publisher · View at Google Scholar · View at Scopus
  7. Chronic Kidney Disease Prognosis Consortium, “Association of estimated glomerular filtration rate and albuminuria with all-cause and cardiovascular mortality in general population cohorts: a collaborative meta-analysis,” The Lancet, vol. 375, no. 9731, pp. 2073–2081, 2010. View at Publisher · View at Google Scholar · View at Scopus
  8. A. S. Go, G. M. Chertow, D. Fan, C. E. McCulloch, and C. Y. Hsu, “Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization,” New England Journal of Medicine, vol. 351, no. 13, pp. 1296–1370, 2004. View at Publisher · View at Google Scholar · View at Scopus
  9. D. S. Keith, G. A. Nichols, C. M. Gullion, J. B. Brown, and D. H. Smith, “Longitudinal follow-up and outcomes among a population with chronic kidney disease in a large managed care organization,” Archives of Internal Medicine, vol. 164, no. 6, pp. 659–663, 2004. View at Publisher · View at Google Scholar · View at Scopus
  10. T. Sanaka, T. Akizawa, K. Koide, and S. Koshikawa, “Clinical analysis of renoprotective responding patients administrated with oral adsorbent in chronic renal failure secondary to chronic glomerulonephritis,” Therapeutic Apheresis, vol. 7, no. 2, pp. 269–278, 2003. View at Publisher · View at Google Scholar · View at Scopus
  11. Z. Al-Aly and O. Cepeda, “Rate of change in kidney function and the risk of death: the case for incorporating the rate of kidney function decline into the CKD staging system,” Nephron, vol. 119, no. 2, pp. c179–c186, 2011. View at Publisher · View at Google Scholar · View at Scopus
  12. B. M. Brenner, M. E. Cooper, D. De Zeeuw et al., “Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy,” New England Journal of Medicine, vol. 345, no. 12, pp. 861–869, 2001. View at Publisher · View at Google Scholar · View at Scopus
  13. E. J. Lewis, L. G. Hunsicker, W. R. Clarke et al., “Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes,” New England Journal of Medicine, vol. 345, no. 12, pp. 851–860, 2001. View at Publisher · View at Google Scholar · View at Scopus
  14. K. Konishi, S. Nakano, S. I. Tsuda, A. Nakagawa, T. Kigoshi, and D. Koya, “AST-120 (Kremezin) initiated in early stage chronic kidney disease stunts the progression of renal dysfunction in type 2 diabetic subjects,” Diabetes Research and Clinical Practice, vol. 81, no. 3, pp. 310–315, 2008. View at Publisher · View at Google Scholar · View at Scopus
  15. T. Shoji, A. Wada, K. Inoue et al., “Prospective randomized study evaluating the efficacy of the spherical adsorptive carbon AST-120 in chronic kidney disease patients with moderate decrease in renal function,” Nephron, vol. 105, no. 3, pp. c99–c107, 2007. View at Publisher · View at Google Scholar · View at Scopus
  16. A. Owada, M. Nakao, J. Koike, K. Ujiie, K. Tomita, and T. Shiigai, “Effects of oral adsorbent AST-120 on the progression of chronic renal failure: a randomized controlled study,” Kidney International, vol. 51, no. 63, pp. S188–S190, 1997. View at Google Scholar · View at Scopus
  17. T. Akizawa, Y. Asano, S. Morita et al., “Effect of carbonaceous oral adsorbent on the progression of CKD: A multicenter, randomized, controlled trial,” American Journal of Kidney Diseases, vol. 54, no. 3, pp. 459–467, 2009. View at Publisher · View at Google Scholar · View at Scopus